ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,808, issued on Aug. 12, was assigned to FORWARD THERAPEUTICS INC. (Palm Beach Gardens, Fla.).
"Modulators of TNF-Alpha activity" was invented by Toufike Kanouni (Palm Beach Gardens, Fla.) and Chris De Savi (Stow, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are inhibitors of TNFAlpha, pharmaceutical compositions comprising the inhibitory compounds, and methods for using the TNFAlpha inhibitory compounds for the treatment of diseases or disorders."
The patent was filed on Nov. 21, 2023, under Application No. 18/516,560.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacg...